1-Bromomethanesulfonamide is an organic compound characterized by the presence of a bromine atom, a methanesulfonamide group, and a sulfonamide functional group. Its molecular structure includes a sulfonamide moiety (-SO2NH2) attached to a bromomethyl group, which contributes to its reactivity and potential applications in organic synthesis. This compound is typically a colorless to pale yellow liquid or solid, depending on its purity and form. It is soluble in polar solvents, such as water and alcohols, due to the presence of the sulfonamide group, which can engage in hydrogen bonding. 1-Bromomethanesulfonamide is often used as a reagent in various chemical reactions, including nucleophilic substitutions and as a building block in the synthesis of more complex molecules. However, it should be handled with care due to its potential toxicity and reactivity, particularly in the presence of strong nucleophiles. Proper safety precautions, including the use of personal protective equipment, are essential when working with this compound.

1-bromomethanesulfonamide

Bromomethanesulfonamide

Bromomethanesulfonamide is a synthetic drug that is used to treat acute lymphoblastic leukemia and hepatitis. It inhibits the activity of the enzyme ns5b polymerase, which is involved in viral replication. Bromomethanesulfonamide is also an NS5B polymerase inhibitor, which may be effective against some types of chronic hepatitis caused by a virus. This drug has been shown to inhibit serotonin synthesis in animals, but this effect has not been observed in humans. Bromomethanesulfonamide has also been used as a control agent for pharmaceutical preparations and carbonic anhydrase inhibitors for glaucoma treatment.

CAS 53412-78-5: 1-bromomethanesulfonamide

Bromomethanesulfonamide

Ref: TR-B124413

Bromomethanesulfonamide

Ref: 3D-DCA41278